Pfizer in talks to merge off-patent drugs business with Mylan: source

  • 📰 Reuters
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a...

Mylan shareholders would receive a little more than 40% of the newly formed entity, with Pfizer shareholders receiving the remainder, the person said, adding that Pfizer would also get about $12 billion in proceeds from a new sale of debt.Last year, Pfizer said it was planning to reorganize into three units, separating its consumer healthcare business.

The restructuring will allow the company to evaluate its businesses better and could result in selling or spinning off its off-patent drugs, Wall Street analysts earlier said.Pfizer and Mylan did not immediately respond to requests for comment. Reporting by Maria Ponnezhath in Bengaluru and Gregory Roumeliotis in New York; Editing by Mark Potter and Paul Simao

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

😂😂😂😂 manche sind auf keine , aber benehmen sich als wären sie es 😂😂😂😂😱😱😱😱

This drug corporation has killed millions and made more addicts,...not to mention their out of world prices

Lets try to decrease the prices on drugs

Mylan was the one that increased the compensation of CEO HeatherBresch (daughter of FakeDem JoeManchin) 600% while jacking up the price of the lifesaving Epipen 400%.

Seriously can we STOP all the mega mergers

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 2. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »

Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
출처: WSJ - 🏆 98. / 63 더 많은 것을 읽으십시오 »

Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »

Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
출처: WSJ - 🏆 98. / 63 더 많은 것을 읽으십시오 »